These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10872892)

  • 61. Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.
    Getahun A; Cambier JC
    Immunol Rev; 2015 Nov; 268(1):66-73. PubMed ID: 26497513
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FcR-mediated inhibition of cell activation and other forms of coinhibition.
    Anderson CC; Sinclair NR
    Crit Rev Immunol; 1998; 18(6):525-44. PubMed ID: 9862092
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Why so many coinhibitory receptors?
    Sinclair NR
    Scand J Immunol; 1999 Jul; 50(1):10-3. PubMed ID: 10404045
    [TBL] [Abstract][Full Text] [Related]  

  • 64. On the origins of adaptive immunity: innate immune receptors join the tale.
    van den Berg TK; Yoder JA; Litman GW
    Trends Immunol; 2004 Jan; 25(1):11-6. PubMed ID: 14698279
    [TBL] [Abstract][Full Text] [Related]  

  • 65. LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets.
    Xiang Z; Yin X; Wei L; Peng M; Zhu Q; Lu X; Guo J; Zhang J; Li X; Zou Y
    Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397424
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Termination of immune activation: an essential component of healthy host immune responses.
    Kane BA; Bryant KJ; McNeil HP; Tedla NT
    J Innate Immun; 2014; 6(6):727-38. PubMed ID: 25033984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 4.